Delivery Order SPE2DB20D1050-SPE2DB25FH90G
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,150.82 to AmerisourceBergen Drug Corp for Mucinex DM ER 600-30 mg tablets (20 count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,332.32 to AmerisourceBergen Drug Corp for Mucinex DM ER 600-30 mg tablets (20-count packages) with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,613.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex DM ER 600-30 mg tablets (20-count packages) on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside award was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,131.24 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mucinex DM ER 600-30 mg tablets (40-count packages). This non-competitive, firm fixed-price delivery order is set to be completed by September 9, 2025, with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mucinex DM ER 600-30 mg tablets in a 40-count package at a firm fixed price of $1,409.00. The contract is unclassified as a set-aside and carries an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,706.85 on July 28, 2025, for the supply of Mucinex DM ER 600-30 mg tablets in quantities of 20 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,620.52 to AmerisourceBergen Drug Corp for Mucinex ER 600 mg tablets (40-count packages) with an ultimate completion date of August 4, 2025. This is a firm fixed-price, non-set-aside contract executed on August 1, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,680.12 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packaging) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,013.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-set-aside delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was issued to AmerisourceBergen's Corporate Office division, with performance to occur at the company's headquarters in...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,129.30 for Mucinex D ER 600-60 mg tablets (18-count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's existing DLA Troop Support Medical Indefinite Delivery Contract (IDC SPE2DX), valued at $999,999,999.00 and extending...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH90GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,005.56 to AmerisourceBergen Drug Corp for Mucinex DM ER 600-30 mg tablets (20-count packages) on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed and delivered from the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As the prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive portfolio of pharmaceuticals, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs globally. This particular delivery order represents a routine transaction within the company's extensive federal contract awards portfolio, which includes medications across multiple therapeutic domains ranging from diabetes and neurological treatments to pain management and antibiotics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/11/25 |